Needle Free Injection Market Research Report – Forecast to 2027

Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2027

ID: MRFR/HC/4721-CR | June 2018 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

The global needle free injection market is anticipated to reach USD 25,057.4 million by 2023, as per a new detailed report by Market Research Future (MRFR). It is expected to exhibit a phenomenal CAGR during the assessment period (2018-2023). Prevalence of various chronic diseases is propelling the need for needle free injections. Rise in investments in the pharmaceutical sector and convenient use of these medical devices in home care is projected to drive market growth over the forecast period.


Needle free injections are syringes which deliver drugs through direct contact with the skin instead of a hypodermic needle. They can be used by children, adults, and patients with allergic conditions without any doctor supervision. It can prevent needle stick injuries, which is a common factor of disease transmission. Increasing incidence of diabetes is anticipated to induce market demand in the coming years. But high cost of these devices and cross-contamination risks can deter market growth.


Report Overview


This report allows the user to gain a deeper understanding of the ongoing events and trends in the global market for needle free injections. By correlating the historical data with key market dynamics, our analysts were able to make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the global needle free injection market segmented by product type, test type, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.


Segment Overview


By product type, the needle free injection market has been segmented into prefilled and fillable needle free injectors. By technology, the market is segmented into laser-powered, spring-based, and jet-based. By usability, the market is segmented into disposable and reusable needle free injectors.  


By medication type, the market is segmented into projectile/depot-based, powder-based, and liquid-based needle free injectors. By site of delivery, intradermal, intramuscular, and subcutaneous are segments in the market. Oncology, vaccination, insulin delivery, and others are major market applications. Prime end-users include ambulatory surgical centers, homecare settings, hospitals and clinics, and others.


The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. For the scope of research, the standard definition of the product/ service “needle free injection” is included in the report. The report discusses and interprets the current and future opportunities of the industry delivering an unbiased growth assessment.


Players Covered


CROSSJECT, Medical International Technology, Inc., National Medical Products Inc., INJEX Pharma GmBH, PenJet Corporation, Valeritas Holdings, Inc., Antares Pharma Inc., D'Antonio Consultants International, Inc., MIKA MEDICAL CO., PharmaJet, Inc., Endo Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., and European Pharma Group are prominent players in the needle free injection market.


The report offers comprehensive profiles on these market players and assesses their current standing in the needle free injection market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, M&A activities, and latest R&D initiatives are outlined in the report.


Research Methodology


Market Research Future (MRFR) uses a combination of primary and secondary research to compile market reports. Primary data is accumulated from interviewing industry stalwarts and secondary research is collated by studying white papers and annual reports of leading players. Our analysts use top-down and bottom-up approaches to validate the findings of the report. The report comprises news, current trends, and future prospects related to the market, all of which can provide a thorough understanding of the market to clients. Industry leaders can make accurate business decisions based on our insights.


Analysis Period



  • Base Year - 2017

  • Projection Period - From 2018 to 2023

  • Market Denomination - USD Million

  • Conversion Rate - Considered as per the respective financial years


Intended Audience



  • Government Research Institutes

  • Research and Development (R&D) Companies

  • Medical Devices Companies

  • Academic Institutes and Universities


For the scope of research, the report offers a comprehensive analysis of the global needle free injection market.


Product Type



  • Prefilled Needle Free Injectors

  • Fillable Needle Free Injectors


Technology



  • Laser-powered

  • Spring-based

  • Jet-based


Usability



  • Disposable Needle Free Injectors

  • Reusable Needle Free Injectors


Type of Medication



  • Liquid-based Needle Free Injectors

  • Powder-based Needle Free Injectors

  • Projectile/Depot-based Needle Free Injectors


Site of Delivery



  • Intradermal Injectors

  • Intramuscular Injectors

  • Subcutaneous Injectors


Application



  • Oncology

  • Vaccination

  • Insulin Delivery

  • Others


End-user



  • Ambulatory Surgical Centers

  • Hospitals & Clinics

  • Homecare Settings

  • Others


Region



  • Americas; North America and South America

  • Europe; Western Europe and Eastern Europe

  • Asia Pacific (APAC); Japan, China, India, South Korea, and Rest of Asia Pacific

  • Middle East & Africa (MEA); The Middle East and Africa



Global Needle Free Injection Market: Report Summary


The global needle free injection market is predicted to touch USD 25,057.4 million by 2023 from USD 10,377.7 million in 2016, expanding at an astounding CAGR of 15.8% during the forecast period (2018-2023). High prevalence of diabetes is the primary factor driving the market. According to the American Diabetes Association, nearly 9.4% of the population in the U.S. reportedly had diabetes. This could result in a large number of users preferring needle free medication owing to low pain levels and fewer chances of contamination. In addition, incidence of chronic diseases and allergies which require accurate doses of medication is another driving factor of the market.


The needle free injection market is segmented on the basis of product type, technology, usability, type of medication, site of delivery, application, and end-user. By product type, the global market for needle free injection is segmented into fillable and prefilled needle free injectors. The fillable needle free injector segment can reportedly gain a higher market share by 2023. This can be attributed to surge in healthcare expenses and demand for protection against needle stick injuries. Technologies include jet-based, spring-based, and laser-powered. Among these, the jet-based segment will command a higher market share till 2023 owing to its rapid delivery of medication. It can rapidly dispense the vaccine over a large area under the skin in less time.


By usability, the market is segmented into reusable and disposable. The reusable segment can touch a valuation of USD 16,445 million by 2023, at a 15.1% CAGR over the forecast period. By type of medication, the market is segmented into liquid-based, powder-based, and projectile/depot-based. The liquid-based segment is anticipated to capture a large market share by 2023 owing to its user-friendly mechanism. By site of delivery, the market is segmented into intradermal, intramuscular, and subcutaneous injectors. The intramuscular segment is touted to expand the fastest due to muscles being the fastest administration route for vaccination. The muscles absorb the vaccine rapidly and dispense it to the bloodstream, expediting the recovery of the patient.


Major applications include oncology, vaccine, insulin delivery, and others. The insulin delivery application can grow robustly owing to high numbers of diabetics requiring insulin shots. On the other hand, the vaccination segment is touted to grow rapidly owing to various government campaigns vouching for the benefits of vaccines. End-users comprise ambulatory surgical centers, hospital & clinics, homecare settings, and others. The hospital and clinics segment is anticipated to dominate the needle free injection market owing to rising demand for painless solutions amid prevalence of cancer and other maladies.


Regional Market Summary


The global needle free injection market, by regions, is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).


The Americas accounted for 34.5% share of the market owing to constant technological advances in pharmaceutical and biotechnology sectors. Increasing demand for self-administering devices, prevalence of chronic diseases, and investments by players in the medical sector can propel its growth over the forecast period. Europe and APAC markets are anticipated to display steady growth rates respectively.


Competitive Analysis


The key players of the global needle free injection market include MIKA MEDICAL CO., PharmaJet, Inc., PenJet Corporation, Inovio Pharmaceuticals Inc., D'Antonio Consultants International, Inc., National Medical Products Inc., Valeritas Holdings, Inc., CROSSJECT, INJEX Pharma GmBH, Endo Pharmaceuticals Inc., Antares Pharma Inc., Medical International Technology, Inc., and European Pharma Group. Rising investments in pharmaceutical and biotechnology sectors can lead to further development in needle free injections.

1 Report Prologue

2 Market Introduction

2.1 Introduction 18

2.2 Assumptions & Limitations 18

3 Research Methodology

3.1 Research Process 21

3.2 Primary Research 21

3.3 Secondary Research 22

3.4 Market Size Estimation 22

4 Market Dynamics

4.1 Introduction 24

4.2 Drivers 24

4.2.1 Increasing Prevalence Of Chronic Conditions Such As Diabetes Is Estimated To Increase The Demand

For Needle-Free Injectors 24

4.2.2 Capacity Of Needle-Free Injectors To Support Homecare 24

4.2.3 Growing Biopharmaceuticals Industry 25

4.2.4 Increasing Investments In The Market 25

4.2.5 Drivers Impact Analysis 25

4.3 Restraints 26

4.3.1 Risks Of Cross Contamination 26

4.3.2 High Cost 26

4.3.3 Restraints Impact Analysis 26

4.4 Opportunity 27

4.4.1 Increasing Campaigns Of Vaccination In Developing Economies Of The Asia Pacific Region 27

4.5 Macroeconomic Indicators 27

5 Market Factor Analysis

5.1 Value Chain Analysis 29

5.1.1 R&D & Designing 29

5.1.2 Manufacturing 29

5.1.3 Distribution & Sales 29

5.1.4 Post-Sales Review 30


5.2 Porter’s Five Forces Model 31

5.2.1 Bargaining Power Of Suppliers 31

5.2.2 Bargaining Power Of Buyers 31

5.2.3 Threat Of New Entrants 32

5.2.4 Threat Of Substitutes 32

5.2.5 Intensity Of Rivalry 32

5.3 Investment Opportunities 32

5.4 Pricing Analysis 32

6 Needle Free Injection Market, By Product

6.1 Introduction 34

6.2 Fillable Needle-Free Injectors 35

6.3 Prefilled Needle-Free Injectors 35

7 Needle Free Injection Market, By Technology

7.1 Introduction 37

7.2 Jet-Based 38

7.3 Spring-Based 38

7.4 Laser-Powered 38

8 Global Needle Free Injection Market, By Usability

8.1 Introduction 40

8.2 Reusable Needle-Free Injectors 41

8.3 Disposable Needle-Free Injectors 41

9 Global Needle Free Injection Market, By Type Of Medication

9.1 Introduction 43

9.2 Liquid-Based Needle Free Injectors 44

9.3 Powder-Based Needle Free Injectors 44

9.4 Projectile/Depot-Based Needle Free Injectors 44

10 Needle Free Injection Market, By Site Of Delivery

10.1 Introduction 46

10.2 Intra Dermal Injectors 47

10.3 Intramuscular Injectors 47

10.4 Subcutaneous Injectors 47

11 Needle Free Injection Market, By Application

11.1 Introduction 49

11.2 Vaccination 50

11.3 Insulin Delivery 50

11.4 Oncology 50

12 Needle Free Injection Market, By End Users

12.1 Introduction 52

12.2 Hospitals And Clinics 53

12.3 Ambulatory Surgical Centres 53

12.4 Homecare Settings 53

13 Global Needle Free Injection Market, By Region

13.1 Introduction 55

13.2 Americas 56

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.2.1 North America 59

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.2.1.1 U.S 61

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.2.1.2 Canada 63

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.2.2 South America 65

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3 Europe 68

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1 Western Europe 71

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.1 Germany 73

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.2 France 75

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.3 U.K 77

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.4 Italy 79

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.5 Spain 81

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.6 Rest Of Western Europe 83

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.2 Eastern Europe 85

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4 Asia Pacific 88

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.1 China 91

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.2 India 93

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.3 Japan 95

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.4 South Korea 97

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.5 Rest Of Asia Pacific 99

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.5 Middle East & Africa 102

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.6 The Middle East 105

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.6.1 Africa 107

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

14 Competitive Landscape

14.1 Introduction 111

14.2 Recent Developments, 2014–2018 111

15 Company Profiles

15.1 Antares Pharma Inc. 114

15.1.1 Company Overview 114

15.1.2 Financial Overview 114

15.1.3 Products Offering 115

15.1.4 Key Developments 115

15.1.5 SWOT Analysis 115

15.1.6 Key Strategy 115

15.2 Endo Pharmaceuticals Inc. 116

15.2.1 Company Overview 116

15.2.2 Financial Overview 116

15.2.3 Products Offering 117

15.2.4 Key Developments 117

15.2.5 SWOT Analysis 117

15.2.6 Key Strategy 117

15.3 PharmaJet, Inc 118

15.3.1 Company Overview 118

15.3.2 Financial Overview 118

15.3.3 Products Offering 118

15.3.4 Key Developments 118

15.3.5 SWOT Analysis 118

15.3.6 Key Strategy 119

15.4 Inovio Pharmaceuticals Inc. 120

15.4.1 Company Overview 120

15.4.2 Financial Overview 120

15.4.3 Products Offering 121

15.4.4 Key Developments 121

15.4.5 SWOT Analysis 121

15.4.6 Key Strategy 121

15.5 Medical International Technology, Inc. 122

15.5.1 Company Overview 122

15.5.2 Financial Overview 122

15.5.3 Products Offering 122

15.5.4 Key Developments 122

15.5.5 SWOT Analysis 123

15.5.6 Key Strategy 123

15.6 INJEX Pharma GmBH 124

15.6.1 Company Overview 124

15.6.2 Financial Overview 124

15.6.3 Products Offering 124

15.6.4 Key Developments 124

15.6.5 SWOT Analysis 124

15.6.6 Key Strategy 124

15.7 National Medical Products Inc. 125

15.7.1 Company Overview 125

15.7.2 Financial Overview 125

15.7.3 Products Offering 125

15.7.4 Key Developments 125

15.7.5 SWOT Analysis 125

15.7.6 Key Strategy 125

15.8 European Pharma Group 126

15.8.1 Company Overview 126

15.8.2 Financial Overview 126

15.8.3 Products Offering 126

15.8.4 Key Developments 126

15.8.5 SWOT Analysis 126

15.8.6 Key Strategy 126

15.9 PenJet Corporation 127

15.9.1 Company Overview 127

15.9.2 Financial Overview 127

15.9.3 Products Offering 127

15.9.4 SWOT Analysis 127

15.9.5 Key Strategy 127

15.10 Valeritas Holdings, Inc. 128

15.10.1 Company Overview 128

15.10.2 Financial Overview 128

15.10.3 Products Offering 128

15.10.4 Key Developments 128

15.10.5 SWOT Analysis 129

15.10.6 Key Strategy 129

15.11 CROSSJECT 130

15.11.1 Company Overview 130

15.11.2 Financial Overview 130

15.11.3 Products Offering 130

15.11.4 Key Developments 130

15.11.5 SWOT Analysis 130

15.11.6 Key Strategy 131

15.12 MIKA MEDICAL CO. 132

15.12.1 Company Overview 132

15.12.2 Financial Overview 132

15.12.3 Products Offering 132

15.12.4 Key Developments 132

15.12.5 SWOT Analysis 132

15.12.6 Key Strategy 132

15.13 D'Antonio Consultants International, Inc. 133

15.13.1 Company Overview 133

15.13.2 Financial Overview 133

15.13.3 Products Offering 133

15.13.4 Key Developments 133

15.13.5 SWOT Analysis 133

15.13.6 Key Strategy 133

16 Appendix

16.1 Discussion Blue Print 135

17 List Of Tables

TABLE 1 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 34

TABLE 2 GLOBAL NEEDLE FREE INJECTION MARKET FOR FILLABLE NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 35

TABLE 3 GLOBAL NEEDLE FREE INJECTION MARKET FOR PREFILLED NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 35

TABLE 4 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 37

TABLE 5 GLOBAL NEEDLE FREE INJECTION MARKET FOR JET-BASED 2020-2027 (USD MILLION) 38

TABLE 6 GLOBAL NEEDLE FREE INJECTION MARKET FOR SPRING-BASED 2020-2027 (USD MILLION) 38

TABLE 7 GLOBAL NEEDLE FREE INJECTION MARKET FOR LASER-POWERED 2020-2027 (USD MILLION) 38

TABLE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 40

TABLE 9 GLOBAL NEEDLE FREE INJECTION MARKET FOR REUSABLE NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 41

TABLE 10 GLOBAL NEEDLE FREE INJECTION MARKET FOR DISPOSABLE NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 41

TABLE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 43

TABLE 12 GLOBAL NEEDLE FREE INJECTION MARKET FOR LIQUID-BASED NEEDLE FREE INJECTORS 2020-2027 (USD MILLION) 44

TABLE 13 GLOBAL NEEDLE FREE INJECTION MARKET FOR POWDER-BASED NEEDLE FREE INJECTORS 2020-2027 (USD MILLION) 44

TABLE 14 GLOBAL NEEDLE FREE INJECTION MARKET FOR PROJECTILE/DEPOT-BASED NEEDLE FREE INJECTORS

2020-2027 (USD MILLION) 44

TABLE 15 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF SITE OF DELIVERY 2020-2027 (USD MILLION) 46

TABLE 16 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRA DERMAL INJECTORS 2020-2027 (USD MILLION) 47

TABLE 17 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRAMUSCULAR INJECTORS 2020-2027 (USD MILLION) 47

TABLE 18 GLOBAL NEEDLE FREE INJECTION MARKET FOR SUBCUTANEOUS INJECTORS 2020-2027 (USD MILLION) 47

TABLE 19 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 49

TABLE 20 GLOBAL NEEDLE FREE INJECTION MARKET FOR VACCINATION 2020-2027 (USD MILLION) 50

TABLE 21 GLOBAL NEEDLE FREE INJECTION MARKET FOR INSULIN DELIVERY 2020-2027 (USD MILLION) 50

TABLE 22 GLOBAL NEEDLE FREE INJECTION MARKET FOR ONCOLOGY 2020-2027 (USD MILLION) 50

TABLE 23 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 52

TABLE 24 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOSPITALS AND CLINICS 2020-2027 (USD MILLION) 53

TABLE 25 GLOBAL NEEDLE FREE INJECTION MARKET FOR AMBULATORY SURGICAL CENTRES 2020-2027 (USD MILLION) 53

TABLE 26 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOMECARE SETTINGS 2020-2027 (USD MILLION) 53

TABLE 27 GLOBAL NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 55

TABLE 28 AMERICAS NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 56

TABLE 29 AMERICAS NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 56

TABLE 30 AMERICAS NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 57

TABLE 31 AMERICAS NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 57

TABLE 32 AMERICAS NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 57

TABLE 33 AMERICAS NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 57

TABLE 34 AMERICAS NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 58

TABLE 35 AMERICAS NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 58

TABLE 36 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 59

TABLE 37 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 59

TABLE 38 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 59

TABLE 39 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 60

TABLE 40 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 60

TABLE 41 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 60

TABLE 42 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 61

TABLE 43 U.S NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 61

TABLE 44 U.S NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 61

TABLE 45 U.S NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 62

TABLE 46 U.S NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 62

TABLE 47 U.S NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 62

TABLE 48 U.S NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 62

TABLE 49 U.S NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 63

TABLE 50 CANADA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 63

TABLE 51 CANADA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 63

TABLE 52 CANADA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 64

TABLE 53 CANADA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 64

TABLE 54 CANADA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 64

TABLE 55 CANADA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 64

TABLE 56 CANADA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 65

TABLE 57 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 65

TABLE 58 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 65

TABLE 59 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 66

TABLE 60 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 66

TABLE 61 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 66

TABLE 62 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 66

TABLE 63 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 67

TABLE 64 EUROPE NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 68

TABLE 65 EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 69

TABLE 66 EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 69

TABLE 67 EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 69

TABLE 68 EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 69

TABLE 69 EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 70

TABLE 70 EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 70

TABLE 71 EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 70

TABLE 72 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 71

TABLE 73 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 71

TABLE 74 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 71

TABLE 75 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 72

TABLE 76 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 72

TABLE 77 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 72

TABLE 78 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 73

TABLE 79 GERMANY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 73

TABLE 80 GERMANY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 73

TABLE 81 GERMANY NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 74

TABLE 82 GERMANY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 74

TABLE 83 GERMANY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 74

TABLE 84 GERMANY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 74

TABLE 85 GERMANY NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 75

TABLE 86 FRANCE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 75

TABLE 87 FRANCE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 75

TABLE 88 FRANCE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 76

TABLE 89 FRANCE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 76

TABLE 90 FRANCE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 76

TABLE 91 FRANCE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 76

TABLE 92 FRANCE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 77

TABLE 93 U.K NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 77

TABLE 94 U.K NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 77

TABLE 95 U.K NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 78

TABLE 96 U.K NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 78

TABLE 97 U.K NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 78

TABLE 98 U.K NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 78

TABLE 99 U.K NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 79

TABLE 100 ITALY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 79

TABLE 101 ITALY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 79

TABLE 102 ITALY NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 80

TABLE 103 ITALY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 80

TABLE 104 ITALY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 80

TABLE 105 ITALY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 80

TABLE 106 ITALY NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 81

TABLE 107 SPAIN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 81

TABLE 108 SPAIN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 81

TABLE 109 SPAIN NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 82

TABLE 110 SPAIN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 82

TABLE 111 SPAIN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 82

TABLE 112 SPAIN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 82

TABLE 113 SPAIN NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 83

TABLE 114 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 83

TABLE 115 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 83

TABLE 116 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 84

TABLE 117 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 84

TABLE 118 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 84

TABLE 119 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 84

TABLE 120 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 85

TABLE 121 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 85

TABLE 122 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 85

TABLE 123 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 86

TABLE 124 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 86

TABLE 125 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 86

TABLE 126 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 86

TABLE 127 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 87

TABLE 128 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 88

TABLE 129 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 88

TABLE 130 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 89

TABLE 131 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 89

TABLE 132 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 89

TABLE 133 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 89

TABLE 134 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 90

TABLE 135 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 90

TABLE 136 CHINA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 91

TABLE 137 CHINA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 91

TABLE 138 CHINA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 91

TABLE 139 CHINA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 92

TABLE 140 CHINA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 92

TABLE 141 CHINA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 92

TABLE 142 CHINA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 93

TABLE 143 INDIA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 93

TABLE 144 INDIA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 93

TABLE 145 INDIA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 94

TABLE 146 INDIA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 94

TABLE 147 INDIA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 94

TABLE 148 INDIA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 94

TABLE 149 INDIA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 95

TABLE 150 JAPAN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 95

TABLE 151 JAPAN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 95

TABLE 152 APAN NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 96

TABLE 153 JAPAN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 96

TABLE 154 JAPAN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 96

TABLE 155 JAPAN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 96

TABLE 156 JAPAN NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 97

TABLE 157 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 97

TABLE 158 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 97

TABLE 159 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 98

TABLE 160 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 98

TABLE 161 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 98

TABLE 162 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 98

TABLE 163 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 99

TABLE 164 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 99

TABLE 165 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 99

TABLE 166 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 100

TABLE 167 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 100

TABLE 168 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 100

TABLE 169 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 100

TABLE 170 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 101

TABLE 171 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 102

TABLE 172 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 102

TABLE 173 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 103

TABLE 174 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 103

TABLE 175 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 103

TABLE 176 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 103

TABLE 177 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 104

TABLE 178 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 104

TABLE 179 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 105

TABLE 180 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 105

TABLE 181 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 105

TABLE 182 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 106

TABLE 183 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 106

TABLE 184 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 106

TABLE 185 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 107

TABLE 186 AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 107

TABLE 187 AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 107

TABLE 188 AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 108

TABLE 189 AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 108

TABLE 190 AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 108

TABLE 191 AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 108

TABLE 192 AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 109


18 List Of Figures

FIGURE 1 MARKET STRUCTURE 19

FIGURE 2 RESEARCH PROCESS 21

FIGURE 3 DROC ANALYSIS OF GLOBAL NEEDLE FREE INJECTION MARKET 24

FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL NEEDLE FREE INJECTION MARKET 25

FIGURE 5 RESTRAINTS IMPACT ANALYSIS: NEEDLE FREE INJECTION MARKET 26

FIGURE 6 VALUE CHAIN: GLOBAL NEEDLE-FREE INJECTION MARKET 29

FIGURE 7 PORTER’S FIVE FORCES MODEL: GLOBAL NEEDLE-FREE INJECTION MARKET 31

FIGURE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020 & 2027 (USD MILLION) 34

FIGURE 9 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020 & 2027 (USD MILLION) 37

FIGURE 10 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2020 & 2027 (USD MILLION) 40

FIGURE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020 & 2027 (USD MILLION) 43

FIGURE 12 GLOBAL NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020 & 2027 (USD MILLION) 46

FIGURE 13 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020 & 2027 (USD MILLION) 49

FIGURE 14 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2020 & 2027 (USD MILLION) 52

FIGURE 15 GLOBAL NEEDLE FREE INJECTION MARKET SHARE BY, REGION 2020 (%) 55

FIGURE 16 AMERICAS NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 56

FIGURE 17 EUROPE NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 68

FIGURE 18 ASIA PACIFIC NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 88

FIGURE 19 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 102

FIGURE 20 GLOBAL NEEDLE FREE INJECTION MARKET, COMPETITIVE LANDSCAPE, 2020 (%) 111



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

A large number of companies are present in the global needle-free injection market. The market players are continuously focusing on the increasing investments to produce novel products and increase their market reach. For instance, the company Antares Pharma received USD 2.75 million from Ferring Pharmaceuticals for its ZOMAJET needle-free auto-injector device. Moreover, it is reported that the U.S. Army Small Business Innovation Research (SBIR) program granted USD 500,000 to Inovio Pharmaceuticals for the development of needle-free delivery technology.


Some of the major market players profiled in the report are Antares Pharma Inc., Inovio Pharmaceuticals Inc., Endo Pharmaceuticals Inc., and Valeritas Holdings, Inc.  


Antares Pharma, a U.S. pharmaceutical company, supplies, designs, and markets self-administered parenteral pharmaceutical products and technologies all over the world. The company has strategic alliances with AMAG Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. The company is focusing on alliances and collaborations to increase its cash flow and bolster sales. For instance, in October 2017, the company announced signing a definitive asset purchase agreement with Ferring Pharmaceuticals to sell the ZOMAJET needle-free auto-injector device for up to USD 14.5 million, thereby increasing its non-dilutive cash.


Inovio Pharmaceuticals Inc. is a worldwide developer, manufacturer, and marketer of pharmaceuticals against cancer and infectious diseases in the United States. The company has entered into an alliance with National Cancer Institute, Roche, MedImmune, Drexel University, University of Pennsylvania, National Institutes of Health (NIH), The Defense Advanced Research Projects Agency (DARPA), HIV Vaccines Trial Network, the U.S. Military HIV Research Program, and the University of Manitoba. The company is majorly focused on partnerships to develop advanced products. For instance, in January 2016, it received funding from government agencies for the development of needle-free electroporation delivery technology, thus changing the paradigm in vaccine administration.


Endo International plc., a pharmaceutical company produces and markets generic as well as branded pharmaceuticals in the United States and internationally.  The company operates through three business segments, namely, the U.S. Generic Pharmaceuticals, International Pharmaceuticals, and the U.S. Branded Pharmaceuticals. The company is focused on expanding its generics and branded pharmaceuticals business by increasing research and development (R&D) investments and acquisitions. For instance, in April 2014, the company announced that it acquired rights from Zogenix, Inc. to sell Sumavel DosePro, a needle-free delivery system. This would fuel its branded pharmaceuticals business worldwide.


Other prominent players in the market include PharmaJet, Inc., Medical International Technology, Inc., INJEX Pharma GmBH, National Medical Products Inc., European Pharma Group, PenJet Corporation, CROSSJECT, MIKA MEDICAL CO., and D'Antonio Consultants International, Inc.